In our previous study, we examined the correlations between pretreatment serum levels of IL-6 and CRP, and the clinicopathological features of CRC, such as tumor size, the presence of distant and lymph node metastases, tumor resectability as well as the prognostic significance of these mediators in patients with CRC [25]. This evidence concerns the gene IL6 and colorectal carcinoma.